# Philip N. Newsome

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/philip-n-newsome/

## Facts

| Field | Value |
| --- | --- |
| Citations | 50,489 |
| Field | Liver Disease Diagnosis and Treatment |
| h-index | 83 |
| i10-index | 219 |
| Last Known Institution | King's College - North Carolina |
| OpenAlex ID | https://openalex.org/A5044832887 |
| ORCID iD | https://orcid.org/0000-0001-6085-3652 |
| Works | 561 |

## Researcher papers

Showing 12 of 18.

- [A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement](https://scholariq.org/papers/a-new-definition-for-metabolic-dysfunction-associated-fatty-liver-disease-an/)
- [MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease](https://scholariq.org/papers/mafld-a-consensus-driven-proposed-nomenclature-for-metabolic-associated-fatty/)
- [A multisociety Delphi consensus statement on new fatty liver disease nomenclature](https://scholariq.org/papers/a-multisociety-delphi-consensus-statement-on-new-fatty-liver-disease/)
- [A multisociety Delphi consensus statement on new fatty liver disease nomenclature](https://scholariq.org/papers/a-multisociety-delphi-consensus-statement-on-new-fatty-liver-disease-3/)
- [A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis](https://scholariq.org/papers/a-placebo-controlled-trial-of-subcutaneous-semaglutide-in-nonalcoholic/)
- [A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis](https://scholariq.org/papers/a-phase-3-randomized-controlled-trial-of-resmetirom-in-nash-with-liver-fibrosis/)
- [Resolving the fibrotic niche of human liver cirrhosis at single-cell level](https://scholariq.org/papers/resolving-the-fibrotic-niche-of-human-liver-cirrhosis-at-single-cell-level/)
- [Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial](https://scholariq.org/papers/obeticholic-acid-for-the-treatment-of-non-alcoholic-steatohepatitis-interim/)
- [Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis](https://scholariq.org/papers/association-between-fibrosis-stage-and-outcomes-of-patients-with-nonalcoholic/)
- [A multisociety Delphi consensus statement on new fatty liver disease nomenclature](https://scholariq.org/papers/a-multisociety-delphi-consensus-statement-on-new-fatty-liver-disease-2/)
- [FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study](https://scholariq.org/papers/fibroscan-ast-fast-score-for-the-non-invasive-identification-of-patients-with/)
- [Advancing the global public health agenda for NAFLD: a consensus statement](https://scholariq.org/papers/advancing-the-global-public-health-agenda-for-nafld-a-consensus-statement/)

## Researcher topics

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [Liver physiology and pathology](https://scholariq.org/topics/liver-physiology-and-pathology/)
- [Mesenchymal stem cell research](https://scholariq.org/topics/mesenchymal-stem-cell-research/)
- [Diet, Metabolism, and Disease](https://scholariq.org/topics/diet-metabolism-and-disease/)

## Researcher university

- [King's College - North Carolina](https://scholariq.org/institutions/king-s-college-north-carolina/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.